Warning letter
Blood Center of New Jersey: warning letter of Apr 15, 2008
FDA warning letter UCM1048339 · New Jersey District Office
Key facts
| Reference number | UCM1048339 |
|---|---|
| Company | Blood Center of New Jersey |
| Subject | Blood Products/Adulterated |
| Issue date | Apr 15, 2008 |
| Posted date | Apr 15, 2008 |
| Issuing office | New Jersey District Office |
| Product type | Biologics |
| CFR sections cited | 606.20, 606.171 |
| Country | 3 |
| Inspection city | East Orange |
| Inspection ZIP | 07018-4106 |
| Inspection start date | Aug 17, 2007 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- VAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: